Zantac Heartburn Medication
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication Zantac exposes users to unsafe levels of the carcinogen N-Nitrosodimethylamine (NDMA). (Dimesky et al v. Sanofi-Aventis U.S., LLC, Sanofi US Services Inc., Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-1517, D. CT.)
Class-Action Tracker
The Latest
Roblox Still Exposing Minors to Deceptive, Harmful Ads
It’s gotten worse.
Brigit Cash Advance App
How fast cash claims can fast track your money problems.
Earth Breeze Laundry Detergent Sheets
TINA.org wades into the marketing of these “eco sheets.”
CATrends: Olive Oils and Olive Oil Blends
Out of the frying pan into court.
Up in Smoke: Legacy Cremation’s Deception and the Families Left Behind
A legacy of adding to consumers’ grief.